Psyneurgy Pharmaceuticals is developing new treatments for psychiatric and neurological disorders. Our current focus is developing an oral treatment to improve restrictive and repetitive behaviors for autism spectrum disorder patients.
Psyneurgy Pharmaceuticals is developing new treatments for psychiatric and neurological disorders. Our current focus is developing an oral treatment to improve restrictive and repetitive behaviors for autism spectrum disorder patients.
Our team has over 30 years of experience in drug development research and working with the pharmaceutical industry. As we continue our promising research, we’re actively pursuing investors and pharmaceutical partners in anticipation of a Phase II clinical trials.
William S. Messer, Jr., Ph.D.
President and Chief Scientific Officer
Austin Horton
Lead Scientist